## CCEP: Coca-Cola Europacific Partners  - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 1.3% below STRENGTH zone (3.0-6.0%); PEG 1.48 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($87.60)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bearish (Bullish: 0, Bearish: 0)

**1. Qube Research & Technologies Ltd Sells 426,266 Shares of Coca-Cola Europacific Partners $CCEP**
- Source: MarketBeat | 20251212T110940 | Somewhat-Bearish | Relevance: 100%
- Qube Research & Technologies Ltd reduced its stake in Coca-Cola Europacific Partners (NASDAQ:CCEP) by 32.9% in the second quarter, selling 426,266 shares and retaining 868,690 shares valued at $80.545 million. The company recently paid a $1.25 dividend, and analysts have a "Moderate Buy" consensus rating with an average target price of $99.33. Institutional investors collectively own about 31.35% of CCEP's stock.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 16.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 1 |

**Top Holders:**
- Invesco Ltd.: 3.5% (+31.6%)
- Blackrock Inc.: 3.4% (-1.3%)
- Vanguard Group Inc: 2.4% (+2.6%)
- Goldman Sachs Group : 1.5% (+6.9%)
- Boston Partners: 1.4% (+2.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +3.6% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.48 suggests fair value with growth premium. Forward P/E 20.4x stretched relative to 9% growth. Institutional flow bullish (8 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $41.3B |
| Beta | 0.38 |
| 52W Range | $73.40 - $100.67 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.48 |
| Forward P/E | 20.4 |
| Current P/E | 22.2 |
| YoY Growth | 8.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.4% to 1.3% (+3.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.7pp (needs >3.0% for momentum thesis). MRS_5 at 2.3% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 52. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.26% (CS: 43) | Neutral |
| RSI_14 | 51.6 | Neutral |
| MACD Histogram | -0.17 | Bearish |
| vs SMA20 | 1.002x | Above |
| vs SMA50 | 1.008x | Above |
| vs SMA200 | 1.007x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $90.80
- **Stop Loss:** $87.60 (3.5% risk)
- **Target:** $94.00 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 374
- **Position Value:** $33,959.20
- **Portfolio %:** 33.96%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-17 (Est: $0.00)

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*